Two Sigma Securities’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,419
Closed -$28.5K 2122
2025
Q4
$28.5K Buy
3,419
+280
+9% +$2.83K ﹤0.01% 1135
2025
Q3
$37.7K Buy
3,139
+884
+39% +$10.8K 0.01% 1030
2025
Q2
$19.1K Buy
2,255
+829
+58% +$8.45K ﹤0.01% 1218
2025
Q1
$16.1K Sell
1,426
-202
-12% -$3.67K ﹤0.01% 1140
2024
Q4
$33.2K Buy
+1,628
New +$47.5K ﹤0.01% 1234
2023
Q1
Sell
-1,038
Closed -$10.5K 3167
2022
Q4
$10.5K Sell
1,038
-362
-26% -$3.87K ﹤0.01% 2350
2022
Q3
$18K Buy
+1,400
New +$21.2K ﹤0.01% 2312
2022
Q1
Sell
-189
Closed -$9K 2440
2021
Q4
$9K Buy
189
+24
+15% +$1.29K ﹤0.01% 1486
2021
Q3
$11K Buy
+165
New +$12.5K ﹤0.01% 1487
2020
Q4
Sell
-223
Closed -$26K 1904
2020
Q3
$26K Buy
+223
New +$38.6K ﹤0.01% 1227

Other funds holding RMTI

Two Sigma Securities's RMTI Position: Q1 2026 in Review

Two Sigma Securities sold out of Rockwell Medical (RMTI) in Q1 2026, closing a stake of 3,419 shares — an estimated $28.5K sold.

Two Sigma Securities first reported a position in RMTI in Q3 2020 and held it in 10 quarters. The position peaked at $37.7K in Q3 2025. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • Two Sigma Securities reported no remaining Rockwell Medical position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 3,419 Rockwell Medical shares in Q1 2026, an estimated $28.5K.
  • Two Sigma Securities first reported a position in Rockwell Medical in Q3 2020 and held it in 10 quarters.
  • Two Sigma Securities's Rockwell Medical position peaked at $37.7K in Q3 2025.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.